These benefits include: Supporting fertility, improving feelings of anxiety or depression, benefits brain health and memory, supports hair, skin and nails, and more
The peptide Epitalon was administered subcutaneously at a dose of 5 mg for ten consecutive days in December 2022, January 2023, and June 2023
Always escalate one compound at a time with at least a two-week stabilization period between escalations
Therapeutically, tachykinin receptor antagonists have been explored in asthma, with some reports suggesting beneficial effects (reviewed here [85])
Research overview Other vial-size protocols Related protocols and comparisons BPC-157 + TB-500 (10 mg Blend) Dosage Protocol BPC-157 + TB-500 (20 mg Blend) Dosage Protocol TB-500 (5 mg) + BPC-157 (5 mg) Stack Dosage Protocol Tri-Heal (45 mg Blend) Dosage Protocol GLOW (70 mg Blend) Dosage Protocol KLOW (80 mg Blend) Dosage Protocol GHK-Cu (50 mg Vial) Dosage Protocol GHK-Cu (100 mg Vial) Dosage Protocol